THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY

Laupacis A, Rorabeck C, Bourne R, et al. THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY. J Bone Joint Surg Br. 1996;78-B(2):210-212. doi:10.1302/0301-620X.78B2.0780210

Laupacis, A., et al. “THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY.” The Journal of Bone & Joint Surgery British Volume, vol. 78-B, no. 2, 1996, pp. 210-212., https://doi.org/10.1302/0301-620X.78B2.0780210

Laupacis, A., Rorabeck, C., Bourne, R., Tugwell, P., Bullas, R., Rankin, R., Vellet, A. D., Feeny, D., & Wong, C. (1996). THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY. The Journal of Bone & Joint Surgery British Volume, 78-B(2), 210-212. https://doi.org/10.1302/0301-620X.78B2.0780210

Laupacis, A., Rorabeck, C., Bourne, R., Tugwell, P., Bullas, R., Rankin, R. et al. (1996) “THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY.” The Journal of Bone & Joint Surgery British Volume, 78-B(2), pp. 210-212. Available at: https://doi.org/10.1302/0301-620X.78B2.0780210

Laupacis, A., C. Rorabeck, R. Bourne, P. Tugwell, R. Bullas, R. Rankin, A. D. Vellet, D. Feeny, and C. Wong. “THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY.” The Journal of Bone & Joint Surgery British Volume 78-B, no. 2 (1996): 210-212. https://doi.org/10.1302/0301-620X.78B2.0780210

Laupacis A, Rorabeck C, Bourne R, Tugwell P, Bullas R, Rankin R, et al. THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY. J Bone Joint Surg Br. 1996 Mar 1;78-B(2):210-212. https://doi.org/10.1302/0301-620X.78B2.0780210

Copy to clipboard

BibTeX

EndNote

RIS

Abstract

We randomised 250 patients undergoing unilateral, elective hip arthroplasty for osteoarthritis to receive either a cemented or a non-cemented Mallory Head prosthesis. Aspirin was used as prophylaxis against thromboembolism during the first half of the study and adjusted-dose warfarin during the second half. Postoperatively, all patients were asked to have bilateral venography and 80% agreed. All were evaluated clinically for pulmonary embolism.

There was no difference in the frequency of deep-venous thrombosis between the two groups (50% cemented v 47% non-cemented, p = 0.73; 95% CI of the difference −13.6% to 19.3%). Three of the 64 patients (5%) in whom venography had demonstrated isolated distal thrombi developed pulmonary emboli.

Correspondence should be sent to Dr A. Laupacis at the Clinical Epidemiology Unit, Loeb Medical Research Institute, Ottawa Civic Hospital, 1053 Carling Avenue, Ottawa, Ontario, Canada K1Y 4E9.

For access options please click here

Figure 1

Some description here

Information

Journal

The Journal of Bone & Joint Surgery British Volume

Volume

78-B No.2 | Pages 210 - 212

Section

Hip

Published

01 March 1996

DOI

Authors

Expand all

A. Laupacis

Division of General Medicine

Search for more articles by this author

C. Rorabeck

Division of Orthopaedics, Department of Surgery

Search for more articles by this author

R. Bourne

Division of Orthopaedics, Department of Surgery

Search for more articles by this author

P. Tugwell

Division of Rheumatology, Department of Medicine, Ottawa General Hospital, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6.

Search for more articles by this author

R. Bullas

Division of Orthopaedics, Department of Surgery

Search for more articles by this author

R. Rankin

Department of Diagnostic Radiology, University Hospital, University of Western Ontario, 339 Windermere Road, London, Ontario, Canada N6A 5A5.

Search for more articles by this author

A. D. Vellet

Department of Radiological Sciences and Diagnostic Imaging, MRI Unit, Foothills Hospital, 1403-29 Street North West, Calgary, Alberta, Canada T2N 2T9.

Search for more articles by this author

D. Feeny

Department of Clinical Epidemiology and Community Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5.

Search for more articles by this author

C. Wong

Clinical Trials Resource Group, Robarts Research Institute, University of Western Ontario, PO Box 5339, London, Ontario, Canada N6A 5A5.

Search for more articles by this author

Keywords

Submit Letter to the Editor

Share article on social media

Facebook